Citation: | LIU Xuewu, ZHOU Zhiming, JIANG Dejian, LONG Li. Protective effect and mechanism of Jinshuibao tablet on acute kidney injury induced by cisplatin in rats[J]. Journal of China Pharmaceutical University, 2020, 51(1): 76-83. DOI: 10.11665/j.issn.1000-5048.20200112 |
[1] |
Chen CJ,Chen CN,Pan QZ,et al.Clinical study on the intervention therapy of Jinshuibao capsule on cisplatins-induced renal toxicity[J].Med Innov China(中国医学创新),2012,9(2):32-33.
|
[2] |
Ye XL,Zhen XC,Yang XL,et al.Diclofenac sodium associated acute kidney injury[J].J ADR(药物不良反应杂志),2018,20(2):146-147.
|
[3] |
Liu W,Jiang SF,Tu L,et al.Mechanism of JinShuiBao capsule in ameliorating rat pneumoconiosis model[J].J China Pharm Univ(中国药科大学学报),2018,49(4):476-482.
|
[4] |
Yan YL,Zhang DM,Wang Y,et al.The comparative study of the effect of intraperitoneal perfusion and intravenous chemotherapy in advanced ovarian cancer[J].J Int Obstet Gynecol(国际妇产科学杂志),2014,41(6):655-657.
|
[5] |
Markman M.Intraperitoneal chemotherapy as primary treatment of advanced ovarian cancer:efficacy,toxicity,and future directions[J].Rev Recent Clin Trials,2007,2(3):169-173.
|
[6] |
Goren O,Matot I.Update on perioperative acute kidney injury[J].Curr Opin Crit Care,2016,22(4):370-378.
|
[7] |
Yan W, Xu Y, Yuan YH, et al. Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury[J].Free Radic Res,2017,51(7/8):669-683.
|
[8] |
Mulay SR,Anders HJ.Crystal nephropathies:mechanisms of crystal-induced kidney injury[J].Nat Rev Nephrol,2017,13(4):226-240.
|
[9] |
Devarajan P.Acute kidney injury:still misunderstood and misdiagnosed[J].Nat Rev Nephrol,2017,13(3):137-138.
|
[10] |
Mansouri A,Ridgway LD,Korapati AL,et al.Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells[J].J Biol Chem,2003,278(21):19245-19256.
|
[11] |
He B,Tao HY,Liu SQ,et al.Carboxymethylated chitosan protects rat chondrocytes from NO-induced apoptosis via inhibition of the p38/MAPK signaling pathway[J].Mol Med Rep,2016,13(3):2151-2158.
|
[12] |
Wang JX,Chen HJ,Cao P,et al.Inflammatory cytokines induce caveolin-1/β-catenin signalling in rat nucleus pulposus cell apoptosis through the p38 MAPK pathway[J].Cell Prolif,2016,49(3):362-372.
|
[13] |
Cai QH,Tang Y,Fan SH,et al.In vivo effects of dexmedetomidine on immune function and tumor growth in rats with ovarian cancer through inhibiting the p38MAPK/NF-κB signaling pathway[J].Biomedecine Pharmacother,2017,95:1830-1837.
|
[14] |
Goldsmith EJ,Min XS,He HX,et al.Structural studies of MAP kinase cascade components[J].Methods Mol Biol,2010,661:223-237.
|
[15] |
Sabio G,Davis RJ.TNF and MAP kinase signalling pathways[J].Semin Immunol,2014,26(3):237-245.
|
[16] |
Ashraf M,Ebner M,Wallner C,et al.A p38MAPK/MK2 signaling pathway leading to redox stress,cell death and ischemia/reperfusion injury[J].Cell Commun Signal,2014,12(1):6.
|
[1] | LI Long, GUO Wei, YU Xiuli, XIE Chunwen. Determination of the related substances in desloratadine by HPLC[J]. Journal of China Pharmaceutical University, 2019, 50(6): 707-712. DOI: 10.11665/j.issn.1000-5048.20190611 |
[2] | XUE Xiaonan, ZHANG Zhengjin, ZOU Qiang, YAN Chao. Determination of dabigatran etexilate mesylate and related substances by HPLC[J]. Journal of China Pharmaceutical University, 2017, 48(6): 711-714. DOI: 10.11665/j.issn.1000-5048.20170612 |
[3] | LUO Yan, GU Jinhua, LUO Zhiteng, WU Jie, YE Lianbao. Synthesis of the related substances of deferasirox[J]. Journal of China Pharmaceutical University, 2016, 47(3): 288-290. DOI: 10.11665/j.issn.1000-5048.20160306 |
[4] | ZHANG Changqing, FAN Rong, WANG Feng. Synthesis of two related substances of everolimus[J]. Journal of China Pharmaceutical University, 2015, 46(2): 174-177. DOI: 10.11665/j.issn.1000-5048.20150206 |
[5] | XU Jie, HU Wenhui, GU Dongfei, HANG Taijun. Identification and determination of related substances in atropine sulfate with hyphenated technique[J]. Journal of China Pharmaceutical University, 2014, 45(4): 438-443. DOI: 10.11665/j.issn.1000-5048.20140410 |
[6] | ZHAO Xun, YUAN Yaozuo, ZHANG Mei, TAN Li. Determination of pyrazinamide and its related substances by HPLC[J]. Journal of China Pharmaceutical University, 2013, 44(6): 536-539. DOI: 10.11665/j.issn.1000-5048.20130609 |
[7] | WANG Shang, ZHENG Feng, DING Li. Determination of related substances of vitamin D3 in its preparations by RP-HPLC[J]. Journal of China Pharmaceutical University, 2012, 43(1): 55-59. |
[8] | XU Ying, WU Qiong-zhu, KE Xue. Determination of moxifloxacin hydrochloride and its related substances by HPLC[J]. Journal of China Pharmaceutical University, 2012, 43(1): 46-50. |
[9] | ZHANG Jin-lin, YUAN Yao-zuo, QIAN Wen, ZHANG Mei. Determination of secnidazole and its related substances by HPLC[J]. Journal of China Pharmaceutical University, 2009, 40(6): 527-530. |
[10] | Determination of Ganciclovir and Its Related Substances by HPLC[J]. Journal of China Pharmaceutical University, 2004, (2): 38-40. |